Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes

NJ Hogrebe, M Ishahak, JR Millman - Cell Stem Cell, 2023 - cell.com
The generation of islet-like endocrine clusters from human pluripotent stem cells (hPSCs)
has the potential to provide an unlimited source of insulin-producing β cells for the treatment …

Macrophage phenotypes in tissue repair and the foreign body response: Implications for biomaterial-based regenerative medicine strategies

KE Martin, AJ García - Acta biomaterialia, 2021 - Elsevier
Macrophages are a highly heterogeneous and plastic population of cells that are crucial for
tissue repair and regeneration. This has made macrophages a particularly attractive target …

[HTML][HTML] Biomaterials to enhance stem cell transplantation

BN Kharbikar, P Mohindra, TA Desai - Cell Stem Cell, 2022 - cell.com
The successful transplantation of stem cells has the potential to transform regenerative
medicine approaches and open promising avenues to repair, replace, and regenerate …

Strategies for durable β cell replacement in type 1 diabetes

TM Brusko, HA Russ, CL Stabler - Science, 2021 - science.org
Technological advancements in blood glucose monitoring and therapeutic insulin
administration have improved the quality of life for people with type 1 diabetes. However …

Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead

A Grattoni, G Korbutt, AA Tomei, AJ García… - Nature Reviews …, 2024 - nature.com
Type 1 diabetes mellitus (T1DM) is a growing global health concern that affects
approximately 8.5 million individuals worldwide. T1DM is characterized by an autoimmune …

[HTML][HTML] Synthesis, properties, and biomedical applications of alginate methacrylate (ALMA)-based hydrogels: Current advances and challenges

M Hasany, S Talebian, S Sadat, N Ranjbar… - Applied Materials …, 2021 - Elsevier
Alginate methacrylate (ALMA) hydrogels have been prevalently used in various biomedical
applications, mainly due to their photocrosslinking ability. Not only this feature allows the …

[HTML][HTML] Type 1 diabetes and engineering enhanced islet transplantation

A Jeyagaran, C Lu, A Zbinden, AL Birkenfeld… - Advanced drug delivery …, 2022 - Elsevier
The development of new therapeutic approaches to treat type 1 diabetes mellitus (T1D)
relies on the precise understanding and deciphering of insulin-secreting β-cell biology, as …

Engineered immunomodulatory accessory cells improve experimental allogeneic islet transplantation without immunosuppression

X Wang, K Wang, M Yu, D Velluto, X Hong, B Wang… - Science …, 2022 - science.org
Islet transplantation has been established as a viable treatment modality for type 1 diabetes.
However, the side effects of the systemic immunosuppression required for patients often …

Towards a functional cure for diabetes using stem cell-derived beta cells: are we there yet?

S Bourgeois, T Sawatani, A Van Mulders, N De Leu… - Cells, 2021 - mdpi.com
Diabetes mellitus is a pandemic metabolic disorder that results from either the autoimmune
destruction or the dysfunction of insulin-producing pancreatic beta cells. A promising cure is …

[HTML][HTML] Emerging immunomodulatory strategies for cell therapeutics

CYX Chua, AY Jiang, T Eufrásio-da-Silva… - Trends in …, 2023 - cell.com
Cellular therapies are poised to transform the field of medicine by restoring dysfunctional
tissues and treating various diseases in a dynamic manner not achievable by conventional …